Bio-hybrid organs and tissues for patient therapy: A future vision for 2030

Chemical Engineering and Processing: Process Intensification

Volumn 51, Issue , 2012, Pages 79-87

  De Bartolo, Loredana ^a   Leindlein, Andreas ^b   Hofmann, Dieter ^b   Bader, Augustinus ^c   de Grey, Aubrey ^d   Curcio, Efrem ^a   Drioli, Enrico ^a,e  

^a UNIVERSITY OF CALABRIA   (Italy)

^b INSTITUTE OF MATERIALS RESEARCH   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d SENS Foundation   (United Kingdom)

^e Hanyang University   (South Korea)

Author keywords

Biohybrid organs; Biomaterials; Bioreactors; Regenerative medicine; Tissue engineering; Tissues

Indexed keywords

AGE-RELATED; BIOARTIFICIAL TISSUES; BIOHYBRID ORGANS; BIOLOGICAL IMPLANT; FUTURE CHALLENGES; LIVER REGENERATION; MEDICAL THERAPY; MULTI-DISCIPLINARY APPROACH; POSITION PAPERS; PROMETHEUS; REGENERATIVE MEDICINE; RESEARCH STRATEGY; SCIENTIFIC FIELDS; SOCIAL NEEDS;

BIOMATERIALS; BIOREACTORS; DISEASE CONTROL; HISTOLOGY; IMPLANTS (SURGICAL); MEDICINE; PATIENT TREATMENT; TISSUE ENGINEERING;

TISSUE;

EID: 84855781641     PISSN: 02552701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cep.2011.09.009     Document Type: Article

References (61)

1. United Network for organs Sharing, http://www.unos.organ/.
2. Koh C.J., Atala A. Tissue engineering, stem cells, and cloning: opportunities for regenerative medicine. J. Am. Soc. Nephrol. 2004, 15:1113-1125.
3. Jagur-Grodzinski J. Polymer for tissue engineering, medical devices and regenerative medicine. Concise general review of recent studies. Polym. Adv. Technol. 2006, 17:395-418.
4. de Grey A., Rae M. Ending Aging 2007, St. Martin's Press, New York.
5. Rouwkema J., Rivron N.C., van Blitterswijk C.A. Vascularization in tissue engineering. Trends Biotechnol. 2008, 26:40-41.
6. 3 plasma-grafted PEEK-WC-PU membranes. Biomaterials 2009, 30:4348-4356.
7. Williams D.F. To engineer is to create: the link between engineering and regeneration. Trends Biotechnol. 2006, 24:4-8.
8. Drioli E., De Bartolo L. Membrane bioreactor for cell tissues and organoids. Artif. Organs 2006, 30:793-802.
9. Hutmacher D.W., Singh H. Computational fluid dynamics for improved bioreactor design and 3D culture. Trends Biotechnol. 2008, 26:166-172.
10. Martin I., Wendt D., Heberer M. The role of bioreactors in tissue engineering. Trends Biotechnol. 2004, 22:80-85.
11. Curcio E., Macchiarini P., De Bartolo L. Oxygen mass transfer in a human tissue-engineered trachea. Biomaterials 2010, 31:5131-5136.
12. Leach J.B., Achyuta A.K., Murthy S.K. Bridging the divide between neuroprosthetic design, tissue engineering and neurobiology. Front. Neuroeng. 2010, 2:1-19.
13. De Bartolo L., Rende M., Morelli S., Giusi G., Salerno S., Piscioneri A., Gordano A., Di Vito A., Canonaco M., Drioli E. Influence of membrane surface properties on the growth of neuronal cells isolated from hippocampus. J. Membr. Sci. 2008, 325:139-149.
14. Morelli S., Salerno S., Piscioneri A., Papenburg B.J., Di Vito A., Giusi G., Canonaco M., Stamatialis D., Drioli E., De Bartolo L. Influence of micropatterned PLLA membranes on the outgrowth and orientation of hippocampal neuritis. Biomaterials 2010, 31:7000-7011.
15. Chae M.S., Liu W., Sivaprakasam M. Design optimization for integrated neural recording systems. IEEE J. Solid State Circuits 2008, 43:1931-1939.
16. Kansaku K., Hata N., Takano K. My thoughts through a robot's eyes: an augmented reality-brain-machine interface. Neurosci. Res. 2010, 66:219-222.
17. Brower V. When mind meets machine. EMBO Rep. 2005, 6:108-110.
18. Birbaumer N., Murguialday A.R., Cohen L. Brain-computer interface in paralysis. Curr. Opin. Neurol. 2008, 21:634-638.
19. Lebl M., Pistek C., Hachmann J., Mudra P., Pesek V., Pokorny V., Poncar P., Zenisek K. Economical parallel oligonucleotide and peptide synthesizer - pet oligator. Int. J. Pept. Res. Ther. 2007, 13:367-375.
20. Shen B., Makley D.M., Johnston J.N. Umpolung reactivity in amide and peptide Synthesis. Nature 2010, 465:1027-1032.
21. Plante O.J., Palmacci E.R., Seeberger P.H. Automated solid-phase synthesis of oligosaccharides. Science 2001, 291:1527.
22. Seeberger P.H., Werz D.B. Synthesis and medical applications of oligosaccharides. Nature 2007, 446:1046-1051.
23. van Heest J.C.M., Tirrell D.A. Protein-based materials: toward a new level of structural control. Chem. Commun. 2001, 19:1897-1904.
24. Tronci G., Neffe A.T., Pierce B.F., Lendlein A. An entropy - elastic gelatin-based hydrogel system. J. Mater. Chem. 2010, published online. 10.1039/c0jm00883d.
25. Mason B.P., Price K.E., Steinbacher J.L., Bogdan A.R., McQuade D.T. Greener approaches to organic synthesis using microreactor technology. Chem. Rev. 2007, 107:2300-2318.
26. Melchels F.P.W., Feijen J., Grijpma D.W. A poly(d,l-lactide) resin for the preparation of tissue engineering scaffolds by stereolithography. Biomaterials 2009, 30:3801-3809.
27. Ovsianikov A., Gruene M., Pflaum M., Koch L., Maiorana F., Wilhelmi M., Haverich A., Chichkov B. Laser printing of cells into 3D scaffolds. Biofabrication 2010, 2:014104. (article number).
28. Cui X., Boland T. Human microvasculature fabrication using thermal inkjet printing technology. Biomaterials 2009, 30:6221-6227.
29. Discher D.E., Janmey P., Wang Y.L. Tissue cells feel and respond to the stiffness of their substrate. Science 2005, 310:1139-1143.
30. Engler A.J., Sen S., Sweeney H.L., Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689.
31. Song Y., Kamphuis M.M.J., Zhang Z., Sterk L.M.T., Vermes I., Poot A.A., Feijen J., Grijpma D.W. Flexible and elastic porous poly(trimethylene carbonate) structures for use in vascular tissue engineering. Acta Biomater. 2010, 6:1269-1277.
32. Velluto D., Demurtas D., Hubbell J.A. PEG-b-PPS diblock copolymer aggregates for hydrophobic drug solubilization and release: cyclosporin A as an example. Mol. Pharm. 2008, 5:632-642.
33. Kim W., Thevenot J., Ibarboure E., Lecommandoux S., Chaikof E.L. Self-assembly of thermally responsive amphiphilic diblock copolypeptides into spherical micellar nanoparticles. Angew. Chem. Int. Ed. 2010, 49:4257-4260.
34. Tu R.S., Tirrell M. Bottom-up design of biomimetic assemblies. Adv. Drug Deliv. Rev. 2004, 56:1537-1563.
35. Behl M., Razzaq M.Y., Lendlein A. Multifunctional shape-memory polymers. Adv. Mater. 2010, 10.1002/adma.200904447.
36. Neffe A.T., Hanh B.D., Steuer S., Wischke C., Lendlein A. Polymer networks combining controlled drug release, biodegradation, and shape memory capability. Adv. Mater. 2009, 21:3394-3398.
37. Shastry V.P., Lendlein A. Materials in regenerative medicine. Adv. Mater. 2009, 21:3231-3234.
38. Shastry V.P., Lendlein A. Engineering materials for regenerative medicine. MRS Bull. 2010, 35:571-575.
39. Schubert T., Steinhoff G., von Ribbeck H.-G., Stutzmannn M., Eickhoff M., Tanaka M. Gallium nitride electrodes for membrane-based electrochemical biosensors. Eur. Phys. J. E 2009, 30:233-238.
40. Neffe A.T., Zaupa A., Pierce B.F., Hofmann D., Lendlein A. Knowledge-based tailoring gelatin-based materials by functionalization with tyrosine-derived groups. Macromol. Rapid Commun. 2010, 31:1534-1539.
41. Zaupa A., Neffe A., Pierce B.F., Lendlein A., Hofmann D. A molecular dynamic and experimental study on physically crosslinked gelatine. Int. J. Artif. Organs 2011, 34:139-151.
42. Urquhart A.J., Anderson D.G., Taylor M., Alexander M.R., Langer R., Davies M.C. High throughput surface characterisation of a combinatorial material library. Adv. Mater. 2007, 19:2486-2491.
43. Hoogenboom R., Schubert U.S. High-throughput synthesis equipment applied to polymer research. Rev. Sci. Instrum. 2005, 76:062202.
44. Langer R., Tirrell D.A. Designing materials for biology and medicine. Nature 2004, 428:487-492.
45. Kou P.M., Babensee J.E. Validation of a high-throughput methodology to assess the effects of biomaterials on dendritic cell phenotype. Acta Biomater. 2010, 6:2621-2630.
46. Bader A., Lorenz K., Richter A., Scheffler K., Kern L., Ebert S., Giri S., Behrens M., Dornseifer U., Macchiarini P., Machens H.G. Role of trauma cytokines and erythropoietin and their therapeutic potential for acute and chronic wounds. Rejuvenation Res. 2011, 14:57-66.
47. De Bartolo L., Salerno S., Curcio E., Piscioneri A., Rende M., Morelli S., Tasselli F., Bader A., Drioli E. Human hepatocyte functions in a crossed hollow fiber membrane bioreactor. Biomaterials 2009, 30:2531-2543.
48. Bader A., Macchiarini P. Moving towards in situ tracheal regeneration: the bionic tissue engineered transplantation approach. J. Cell. Mol. Med. 2010, 14:1877-1879.
49. Zscharnack M., Hepp P., Richter R., Aigner T., Schulz R., Somerson J., Josten C., Bader A., Marquass B. Repair of chronic osteochondral defects using predifferentiated mesenchymal stem cells in an ovine model. Am. J. Sports Med. 2010, 38:1857-1869.
50. Maringka M., Giri S., Nieber K., Açikgöz A., Bader A. Biotransformation of diazepam in a clinical relevant flat membrane bioreactor model using primary porcine hepatocytes. Fundam. Clin. Pharmacol. 2010, 25:343-353.
51. Bader A., Machens H.G. Recombinant human erythropoietin plays a pivotal role as a topical stem cell activator to reverse effects of damage to the skin in aging and trauma. Rejuvenation Res. 2010, 13:499-500.
52. Steinhoff G., Stock U., Karim N., Mertsching H., Timke A., Meliss R., Pethig K., Haverich A., Bader A. Tissue engineering of pulmonary heart valves on allogeneic acellular matrix conduits in vivo restoration of valve tissue. Circulation 2000, 102. III50-55.
53. Bader A., Schilling T., Teebken O., Brandes G., Steinhoff G., Haverich A. Tissue engineering of heart valves - human endothelial cell seeding of detergent acellularized porcine valves. J. Cardiovasc. Surg. 1998, 14:279-284.
54. Karim N., Golz K., Bader A. The cardiovascular tissue-reactor: a novel device for the engineering of heart valves. Artif. Organs 2006, 30:809-814.
55. Galle J., Bader A., Hepp P., Grill W., Fuchs B., Kas J.A., Krinner A., Marquass B., Muller K., Schiller J., Schulz R.M., von Buttlar M., von der Burg E., Zscharnack M., Loffler M. Mesenchymal stem cells in cartilage repair: state of the art and methods to monitor cell growth, differentiation and cartilage regeneration. Curr. Med. Chem. 2010, 17:2274-2291.
56. Schulz R.M., Wüstneck N., van Donkelaar C., Shelton J., Bader A. Development and validation of a novel bioreactor system for load- and perfusion-controlled tissue engineering of chondrocyte-constructs. Biotechnol. Bioeng. 2008, 101:714-728.
57. De Bartolo L., Jarosch-Von Schweder G., Haverich A., Bader A. A novel full-scale flat membrane bioreactor utilizing porcine hepatocytes: cell viability and tissue specific functions. Biotechnol. Prog. 2000, 16:102-108.
58. de Grey A.D.N.J., Ames B.N., Andersen J.K., Bartke A., Campisi J., Heward C.B., McCarter R.J.M., Stock G. Time to talk SENS: critiquing the immutability of human aging. Ann. N. Y. Acad. Sci. 2002, 959:452-462.
59. de Grey A.D.N.J. A strategy for postponing aging indefinitely. Stud. Health Technol. Inform. 2005, 118:209-219.
60. de Grey A.D.N.J., Alvarez P.J.J., Brady R.O., Cuervo A.M., Jerome W.G., McCarty P.L., Nixon R.A., Rittmann B.E., Sparrow J.R. Medical bioremediation: prospects for the application of microbial catabolic diversity to aging and several major age-related diseases. Ageing Res. Rev. 2005, 4:315-338.
61. de Grey A.D.N.J. Foreseeable pharmaceutical repair of age-related extracellular damage. Curr. Drug Targets 2006, 7:1469-1477.